Today’s Top Tech- March 6, 2018

0
1276
Tech stock news

(LXGTF) Clinical Trial Update

Have you been paying attention to Lexington Biosciences (LXGTF) lately? Right now, (LXGTF) is hovering around $0.40 and could be on the verge of some key market catalysts that we think show strong potential! Yesterday’s news could put our members on the cusp of something BIG for (LXGTF).

VANCOUVER, British Columbia, March 05, 2018. Lexington (LXGTF) Cardiovascular Health Monitor Performing as Designed with First Clinical Patients.

FULL DETAILS HERE!

 

 


Disclaimer: TechStockInsider.com is owned by Midam Ventures, LLC & has been compensated $100,000.00 by Ellis Stewart, LLC for a period beginning October 1, 2017 and ending November. 1, 2017 & Midam Ventures, LLC has been compensated an additional $150,000.00 by Ellis Stewart, LLC for a period beginning November 1, 2017 and ending December. 1, 2017 & Midam Ventures, LLC has been compensated an additional $150,000.00 by Ellis Stewart, LLC for a period beginning December 1, 2017 and ending December 31, 2017 to publicly disseminate information about (LXGTF). We may buy or sell additional shares of (LXGTF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. Midam Ventures, LLC has been compensated an additional $250,000.00 by Ellis Stewart, LLC for a period beginning January 1, 2018 and ending February 1, 2018 to publicly disseminate information about (LXGTF). We may buy or sell additional shares of (LXGTF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Midam Ventures, LLC has been compensated an additional $100,000.00 by Ellis Stewart, LLC for a period beginning February 26, 2018 and ending March 30, 2018 to publicly disseminate information about (LXGTF). We may buy or sell additional shares of (LXGTF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. Full Disclaimer Click Here

LEAVE A REPLY

Please enter your comment!
Please enter your name here